Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19110 | 455 | 42.8 | 69% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 88 | 25697 | ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ADHERENT INVASIVE E COLI | Author keyword | 13 | 71% | 2% | 10 |
| 2 | ADHERENT INVASIVE ESCHERICHIA COLI | Author keyword | 7 | 57% | 2% | 8 |
| 3 | JE2526 | Address | 7 | 67% | 1% | 6 |
| 4 | USC 2018 | Address | 6 | 43% | 2% | 10 |
| 5 | M2ISH | Address | 4 | 47% | 2% | 7 |
| 6 | PATHOGENIE BACTERIENNE INTESTINALE | Address | 4 | 75% | 1% | 3 |
| 7 | UMR INSERM 1071 | Address | 3 | 57% | 1% | 4 |
| 8 | RECH MALAD INFLAMMATOI INTESTIN | Address | 3 | 60% | 1% | 3 |
| 9 | USC INRA 2018 | Address | 3 | 42% | 1% | 5 |
| 10 | GASTROENTEROL OPERAT UNIT | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ADHERENT INVASIVE E COLI | 13 | 71% | 2% | 10 | Search ADHERENT+INVASIVE+E+COLI | Search ADHERENT+INVASIVE+E+COLI |
| 2 | ADHERENT INVASIVE ESCHERICHIA COLI | 7 | 57% | 2% | 8 | Search ADHERENT+INVASIVE+ESCHERICHIA+COLI | Search ADHERENT+INVASIVE+ESCHERICHIA+COLI |
| 3 | AIEC | 2 | 36% | 1% | 4 | Search AIEC | Search AIEC |
| 4 | FECAL STREAM | 1 | 100% | 0% | 2 | Search FECAL+STREAM | Search FECAL+STREAM |
| 5 | MUCOSAL BACTERIA | 1 | 50% | 0% | 2 | Search MUCOSAL+BACTERIA | Search MUCOSAL+BACTERIA |
| 6 | FUSOBACTERIUM VARIUM | 1 | 25% | 1% | 3 | Search FUSOBACTERIUM+VARIUM | Search FUSOBACTERIUM+VARIUM |
| 7 | ADHERENT INVASIVE E | 1 | 50% | 0% | 1 | Search ADHERENT+INVASIVE+E | Search ADHERENT+INVASIVE+E |
| 8 | ANTIBIOTICS COMBINATION THERAPY | 1 | 50% | 0% | 1 | Search ANTIBIOTICS+COMBINATION+THERAPY | Search ANTIBIOTICS+COMBINATION+THERAPY |
| 9 | B VULGATUS | 1 | 50% | 0% | 1 | Search B+VULGATUS | Search B+VULGATUS |
| 10 | COMMENSAL MICROBES | 1 | 50% | 0% | 1 | Search COMMENSAL+MICROBES | Search COMMENSAL+MICROBES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ILEAL MUCOSA | 51 | 39% | 23% | 104 |
| 2 | STRAIN LF82 | 31 | 76% | 5% | 22 |
| 3 | INVASIVE E COLI | 11 | 67% | 2% | 10 |
| 4 | NEOTERMINAL ILEUM | 10 | 57% | 3% | 12 |
| 5 | INVASIVE ESCHERICHIA COLI | 9 | 25% | 7% | 30 |
| 6 | ANTIBIOTIC COMBINATION THERAPY | 8 | 60% | 2% | 9 |
| 7 | ANTIMYCOBACTERIAL CHEMOTHERAPY | 6 | 80% | 1% | 4 |
| 8 | COMBINATION CIPROFLOXACIN | 6 | 100% | 1% | 4 |
| 9 | ANTIMYCOBACTERIAL THERAPY | 5 | 38% | 2% | 11 |
| 10 | METRONIDAZOLE PLUS CIPROFLOXACIN | 3 | 30% | 2% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis | 2011 | 110 | 48 | 54% |
| A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease | 2006 | 30 | 22 | 68% |
| The role of antimicrobials in Crohn's disease | 2013 | 1 | 23 | 57% |
| Intestinal bacteria and inflammatory bowel disease | 2009 | 38 | 207 | 24% |
| Pathogenesis of adherent-invasive Escherichia coli | 2013 | 3 | 100 | 35% |
| Adherent-invasive Escherichia coli in inflammatory bowel disease | 2007 | 77 | 79 | 28% |
| Use of antibiotics in the treatment of inflammatory bowel disease | 2006 | 33 | 120 | 34% |
| Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis | 2015 | 0 | 27 | 48% |
| Evidence for the involvement of infectious agents in the pathogenesis of Crohn"s disease | 2008 | 35 | 108 | 20% |
| Mucosal Biofilm Communities in the Human Intestinal Tract | 2011 | 17 | 111 | 23% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JE2526 | 7 | 67% | 1.3% | 6 |
| 2 | USC 2018 | 6 | 43% | 2.2% | 10 |
| 3 | M2ISH | 4 | 47% | 1.5% | 7 |
| 4 | PATHOGENIE BACTERIENNE INTESTINALE | 4 | 75% | 0.7% | 3 |
| 5 | UMR INSERM 1071 | 3 | 57% | 0.9% | 4 |
| 6 | RECH MALAD INFLAMMATOI INTESTIN | 3 | 60% | 0.7% | 3 |
| 7 | USC INRA 2018 | 3 | 42% | 1.1% | 5 |
| 8 | GASTROENTEROL OPERAT UNIT | 2 | 67% | 0.4% | 2 |
| 9 | UMR1071 | 2 | 67% | 0.4% | 2 |
| 10 | UMR 1071 | 2 | 26% | 1.1% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000163137 | DEXTRAN SULFATE SODIUM//EXPERIMENTAL COLITIS//BIOL CHEM BIOACT |
| 2 | 0.0000138638 | ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES//ASCA//ANTI SACCHAROMYCES CEREVISIAE ANTIBODY |
| 3 | 0.0000136025 | MESALAZINE//5 AMINOSALICYLIC ACID//MESALAMINE |
| 4 | 0.0000131332 | GUT MICROBIOTA//MICROBIOTA//MICROBIOME |
| 5 | 0.0000114493 | SEVERE ULCERATIVE COLITIS//TOXIC MEGACOLON//STEROID REFRACTORY ULCERATIVE COLITIS |
| 6 | 0.0000109528 | NOD2//CARD15//NOD1 |
| 7 | 0.0000106915 | PARA TUBERCULOSIS//JOHNES DISEASE//MYCOBACTERIUM AVIUM SUBSP PARATUBERCULOSIS |
| 8 | 0.0000106719 | EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE//MONTREAL CLASSIFICATION//INDETERMINATE COLITIS |
| 9 | 0.0000094844 | INTESTINAL INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTE IEL |
| 10 | 0.0000083281 | PROBIOTICS//ESCHERICHIA COLI NISSLE 1917//LACTOBACILLUS GG |